| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |